METHOD OF DIAGNOSING β2 MICROGLOBULIN AMYLOIDOSIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE OF FIFTH STAGE WHO ARE ON RENAL REPLACEMENT THERAPY Russian patent published in 2013 - IPC A61B8/00 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to therapy and functional diagnostics, and can be used for diagnostics of β2-microglobulin amyloidosis in patients with chronic kidney disease of fifth stage, who are on renal replacement therapy. For this purpose ultrasonic examination of shoulder and hip joints is performed. Thickness of tendon of shoulder joint subcapularis muscle and thickness of neck-capsular space of hip joint are estimated. If values of thickness of tendon of shoulder joint subcapularis muscle are higher than 8 mm and those of thickness of neck-capsular space of hip joint are higher than 10 mm, β2-microglobulin amyloidosis is diagnosed.

EFFECT: method makes it possible to diagnose β2-microglobulin amyloidosis in said category of patients without application of invasive diagnostic methods, and start treatment procedures in due time in case of necessity

2 ex, 2 tbl